Open Access

Downregulation of LRIG2 expression inhibits angiogenesis of glioma via EGFR/VEGF‑A pathway

  • Authors:
    • Hong‑Kuan Yang
    • Hao Chen
    • Feng Mao
    • Qun‑Gen Xiao
    • Rui‑Fan Xie
    • Ting Lei
  • View Affiliations

  • Published online on: July 26, 2017     https://doi.org/10.3892/ol.2017.6671
  • Pages: 4021-4028
  • Copyright: © Yang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Active angiogenesis is the basic pathological feature of glioma. Tumor angiogenesis is involved in vascular endothelial cell migration to the tumor tissue and in the formation of tube‑like structures. The present study aimed to investigate the role of leucine‑rich repeats and immunoglobulin‑like domains 2 (LRIG2) in glioma angiogenesis. Glioma (n=50) and normal brain (n=20) tissue samples were collected from patients to detect the expression of LRIG2, epidermal growth factor receptor (EGFR), vascular endothelial growth factor A (VEGF‑A), and cluster of differentiation 31 (CD31) using immunohistochemistry. In addition, the association between the expression of LRIG2 in glioma tissue and the microvessel density (MVD) was analyzed. In vitro, the expression of LRIG2 in human glioma U87 and U251 cell lines was knocked down. Subsequently, cell migration and tube formation assays of human umbilical vein endothelial cells (HUVECs) were performed using a coculture system. The protein expression levels of LRIG2, EGFR, phosphorylated‑EGFR and VEGF‑A were determined using western blotting. The results demonstrated that the expression levels of LRIG2, EGFR, VEGF‑A and CD31 were highly upregulated in glioma tissue samples. Furthermore, LRIG2 expression in glioma tissue samples was significantly correlated with the MVD. In vitro, the downregulation of LRIG2 inhibited HUVEC migration and tube formation induced by coculture with glioma cells. The downregulation of LRIG2 resulted in decreased expression of EGFR and VEGF‑A. The effects of the LRIG2 knockdown were reversed following EGF treatment. These findings suggest that LRIG2 is a potential target for the inhibition of glioma angiogenesis, which is possibly mediated via the EGFR/VEGF‑A signaling pathway.
View Figures
View References

Related Articles

Journal Cover

October-2017
Volume 14 Issue 4

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yang HK, Chen H, Mao F, Xiao QG, Xie RF and Lei T: Downregulation of LRIG2 expression inhibits angiogenesis of glioma via EGFR/VEGF‑A pathway. Oncol Lett 14: 4021-4028, 2017
APA
Yang, H., Chen, H., Mao, F., Xiao, Q., Xie, R., & Lei, T. (2017). Downregulation of LRIG2 expression inhibits angiogenesis of glioma via EGFR/VEGF‑A pathway. Oncology Letters, 14, 4021-4028. https://doi.org/10.3892/ol.2017.6671
MLA
Yang, H., Chen, H., Mao, F., Xiao, Q., Xie, R., Lei, T."Downregulation of LRIG2 expression inhibits angiogenesis of glioma via EGFR/VEGF‑A pathway". Oncology Letters 14.4 (2017): 4021-4028.
Chicago
Yang, H., Chen, H., Mao, F., Xiao, Q., Xie, R., Lei, T."Downregulation of LRIG2 expression inhibits angiogenesis of glioma via EGFR/VEGF‑A pathway". Oncology Letters 14, no. 4 (2017): 4021-4028. https://doi.org/10.3892/ol.2017.6671